{"id":653062,"date":"2026-05-26T11:26:53","date_gmt":"2026-05-26T14:26:53","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=653062"},"modified":"2026-05-26T11:26:55","modified_gmt":"2026-05-26T14:26:55","slug":"ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/","title":{"rendered":"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa"},"content":{"rendered":"<p>Ap\u00f3s obter o registro na Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) para o medicamento Ozivy, a farmac\u00eautica EMS quer centrar seus esfor\u00e7os na produ\u00e7\u00e3o desse rem\u00e9dio, visando coloc\u00e1-lo no mercado em 30 dias.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-800x450.webp\" width=\"800\" height=\"450\" alt=\"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">EMS acelera lan\u00e7amento do Ozivy ap\u00f3s aprova\u00e7\u00e3o da Anvisa para disputar mercado da semaglutida.<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-da-vida-financeira\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/400x300-Planilha-vida-financeira-true.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t\tdata-promo-id=\"383123\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n\n\n\n<p>Segundo o vice-presidente da companhia, Marcus Sanchez, a semaglutida \u00e9 um produto de alta demanda e com forte procura reprimida no Pa\u00eds, o que abre espa\u00e7o para a entrada de novos competidores. &#8220;A gente entende que a semaglutida \u00e9 um produto extremamente desejado, com uma demanda muito grande&#8221;, afirmou. Nesse contexto, a EMS pretende se posicionar como uma alternativa para m\u00e9dicos e pacientes, ampliando o acesso ao tratamento.<\/p>\n\n\n\n<p>Embora o pre\u00e7o ainda n\u00e3o esteja definido, a empresa afirma que trabalhar\u00e1 com foco em acessibilidade. A estrat\u00e9gia inclui oferecer condi\u00e7\u00f5es mais vantajosas no in\u00edcio do tratamento e um valor final competitivo em rela\u00e7\u00e3o aos produtos j\u00e1 dispon\u00edveis no mercado. &#8220;Ainda n\u00e3o temos o pre\u00e7o fechado, mas entendemos que conseguiremos gerar acesso&#8221;, disse Sanchez.<\/p>\n\n\n\n<p>A farmac\u00eautica tamb\u00e9m mira a demanda atualmente atendida por canais informais. De acordo com o executivo, parte do consumo hoje ocorre por meio de produtos vindos do exterior ou de formula\u00e7\u00f5es n\u00e3o regularizadas, cen\u00e1rio que tende a mudar com a amplia\u00e7\u00e3o da oferta oficial. &#8220;Estamos focados em atender \u00e0 demanda reprimida do mercado. Hoje, parte dessa demanda \u00e9 suprida por mercado paralelo&#8221;, afirmou.<\/p>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/ebook-como-analisar-uma-acao\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Mobile.jpg\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t\tdata-promo-id=\"378302\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='286'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n\n\n\n<p>Para garantir o abastecimento, a EMS destaca que conta com capacidade produtiva relevante. S\u00e3o duas linhas de produ\u00e7\u00e3o, com potencial de at\u00e9 40 milh\u00f5es de canetas por ano. A empresa, no entanto, reconhece que o comportamento da demanda ainda \u00e9 incerto e diz trabalhar para evitar eventuais faltas. &#8220;Esperamos ter capacidade produtiva suficiente para atender ao mercado e estamos trabalhando para que n\u00e3o ocorra desabastecimento&#8221;, disse Sanchez.<\/p>\n\n\n\n<p>No lan\u00e7amento, a companhia prev\u00ea colocar 350 mil unidades no mercado, com distribui\u00e7\u00e3o mais pulverizada entre redes farmac\u00eauticas. A expectativa \u00e9 comercializar mais de 1 milh\u00e3o de canetas no per\u00edodo de um ano, com faturamento superior a R$ 500 milh\u00f5es. &#8220;Podemos surpreender positivamente, a depender da demanda&#8221;, afirmou o executivo.<\/p>\n\n\n\n<p>O lan\u00e7amento do produto marca um avan\u00e7o da EMS em sua plataforma de pept\u00eddeos, desenvolvida ao longo da \u00faltima d\u00e9cada com investimentos superiores a R$ 1,2 bilh\u00e3o. A companhia aposta que a entrada no mercado de semaglutida deve refor\u00e7ar seu posicionamento como uma empresa capaz de combinar inova\u00e7\u00e3o com escala e amplia\u00e7\u00e3o de acesso a medicamentos.<\/p>\n\n\n\n<p class=\"newsProviderSignature\">Com Estad\u00e3o Conte\u00fado<\/p>\n\n\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-da-vida-financeira\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/400x300-Planilha-vida-financeira-true.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t\tdata-promo-id=\"106682\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Ap\u00f3s obter o registro na Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) para o medicamento Ozivy, a farmac\u00eautica EMS quer centrar seus esfor\u00e7os na produ\u00e7\u00e3o desse rem\u00e9dio, visando coloc\u00e1-lo no mercado em 30 dias. EMS acelera lan\u00e7amento do Ozivy ap\u00f3s aprova\u00e7\u00e3o da Anvisa para disputar mercado da semaglutida. Segundo o vice-presidente da companhia, Marcus Sanchez, a [&hellip;]<\/p>\n","protected":false},"author":43,"featured_media":653074,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[],"suno_strategy":[],"class_list":["post-653062","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval<\/title>\n<meta name=\"description\" content=\"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval\" \/>\n<meta property=\"og:description\" content=\"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/sunonoticias\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"454\" \/>\n\t<meta property=\"og:image:height\" content=\"311\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Reda\u00e7\u00e3o Suno Not\u00edcias\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reda\u00e7\u00e3o Suno Not\u00edcias\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\"},\"author\":{\"name\":\"Reda\u00e7\u00e3o Suno Not\u00edcias\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/c1b1bd3727fa852bd045e9dbff3673ea\"},\"headline\":\"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa\",\"datePublished\":\"2026-05-26T14:26:53+00:00\",\"dateModified\":\"2026-05-26T14:26:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\"},\"wordCount\":453,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp\",\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\",\"name\":\"EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp\",\"datePublished\":\"2026-05-26T14:26:53+00:00\",\"dateModified\":\"2026-05-26T14:26:55+00:00\",\"description\":\"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp\",\"width\":454,\"height\":311,\"caption\":\"EMS acelera lan\u00e7amento do Ozivy ap\u00f3s aprova\u00e7\u00e3o da Anvisa para disputar mercado da semaglutida.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/c1b1bd3727fa852bd045e9dbff3673ea\",\"name\":\"Reda\u00e7\u00e3o Suno Not\u00edcias\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b8104b9b5a71985d5238ee59fbe418af?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b8104b9b5a71985d5238ee59fbe418af?s=96&r=g\",\"caption\":\"Reda\u00e7\u00e3o Suno Not\u00edcias\"},\"description\":\"O Suno Not\u00edcias \u00e9 um portal de informa\u00e7\u00f5es sobre Mercado Financeiro, Pol\u00edtica, Neg\u00f3cios, Economia e Finan\u00e7as Pessoais.\",\"sameAs\":[\"https:\/\/www.suno.com.br\/noticias\",\"https:\/\/www.facebook.com\/sunonoticias\/\",\"https:\/\/www.instagram.com\/sunonoticias\/\",\"https:\/\/x.com\/https:\/\/twitter.com\/sunoresearch\",\"https:\/\/www.youtube.com\/sunonoticias\"],\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/redacao-suno\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval","description":"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/","og_locale":"pt_BR","og_type":"article","og_title":"EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval","og_description":"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.","og_url":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","article_author":"https:\/\/www.facebook.com\/sunonoticias\/","og_image":[{"width":454,"height":311,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp","type":"image\/jpeg"}],"author":"Reda\u00e7\u00e3o Suno Not\u00edcias","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Reda\u00e7\u00e3o Suno Not\u00edcias","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/"},"author":{"name":"Reda\u00e7\u00e3o Suno Not\u00edcias","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/c1b1bd3727fa852bd045e9dbff3673ea"},"headline":"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa","datePublished":"2026-05-26T14:26:53+00:00","dateModified":"2026-05-26T14:26:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/"},"wordCount":453,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp","articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/","url":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/","name":"EMS prepara lan\u00e7amento de rival do Ozempic ap\u00f3s aval","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp","datePublished":"2026-05-26T14:26:53+00:00","dateModified":"2026-05-26T14:26:55+00:00","description":"EMS quer lan\u00e7ar o Ozivy, rival do Ozempic, em at\u00e9 30 dias ap\u00f3s aval da Anvisa, mirando demanda reprimida no mercado brasileiro.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711.webp","width":454,"height":311,"caption":"EMS acelera lan\u00e7amento do Ozivy ap\u00f3s aprova\u00e7\u00e3o da Anvisa para disputar mercado da semaglutida."},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/c1b1bd3727fa852bd045e9dbff3673ea","name":"Reda\u00e7\u00e3o Suno Not\u00edcias","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b8104b9b5a71985d5238ee59fbe418af?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b8104b9b5a71985d5238ee59fbe418af?s=96&r=g","caption":"Reda\u00e7\u00e3o Suno Not\u00edcias"},"description":"O Suno Not\u00edcias \u00e9 um portal de informa\u00e7\u00f5es sobre Mercado Financeiro, Pol\u00edtica, Neg\u00f3cios, Economia e Finan\u00e7as Pessoais.","sameAs":["https:\/\/www.suno.com.br\/noticias","https:\/\/www.facebook.com\/sunonoticias\/","https:\/\/www.instagram.com\/sunonoticias\/","https:\/\/x.com\/https:\/\/twitter.com\/sunoresearch","https:\/\/www.youtube.com\/sunonoticias"],"url":"https:\/\/www.suno.com.br\/noticias\/author\/redacao-suno\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2026\/05\/ems-jpeg-e1779805584711-400x200.webp\" alt=\"EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/ems-rival-ozempic-anvisa-lancamento-30-dias-ozivy-mtae\/\"><h2 class=\"content__title\">EMS quer rival do Ozempic nas farm\u00e1cias em 30 dias ap\u00f3s aval da Anvisa<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/redacao-suno\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2020\/08\/0ace682d-redacao-1-150x150.webp\" alt=\"Reda\u00e7\u00e3o Suno Not\u00edcias\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/redacao-suno\/\"><span itemprop=\"author\">Reda\u00e7\u00e3o Suno Not\u00edcias<\/span><\/a><\/span><time datetime=\"2026-05-26T11:26:53-03:00\" itemprop=\"datePublished\">26\/05\/2026 11:26<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/653062"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=653062"}],"version-history":[{"count":1,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/653062\/revisions"}],"predecessor-version":[{"id":653075,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/653062\/revisions\/653075"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/653074"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=653062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=653062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=653062"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=653062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}